Triple-negative breast cancers (TNBC) comprise a heterogeneous subgroup of tumors with a generally poor prognosis. Subclassification of TNBC based on genomic analyses shows that basal-like TNBCs, specifically the basal A or BL2 subtype, are characterized by the expression of ΔNp63, a transcription factor that has been attributed a variety of roles in the regulation of proliferation, differentiation, and cell survival. To investigate the role(s) of p63 in basal-like breast cancers, we used HCC1806 cells that are classified as basal A/BL2. We show that these cells endogenously express p63, mainly as the ΔNp63α isoform. TP63 gene knockout by CRISPR resulted in viable cells that proliferate more slowly and adhere less tightly, with an increased rate of migration. Analysis of adhesion-related gene expression revealed a complex set of alterations in p63-depleted cells, with both increased and decreased adhesion molecules and adhesion substrates compared to parental cells expressing p63. Examination of the phenotype of these cells indicated that endogenous p63 is required to suppress the expression of luminal markers and maintain the basal epithelial phenotype, with increased levels of both CK8 and CK18 and a reduction in N-cadherin levels in cells lacking p63. On the other hand, the level of CK5 was not decreased and ER was not increased, indicating that p63 loss is insufficient to induce full luminal-type differentiation. Taken together, these data demonstrate that p63 exerts multiple pro-oncogenic effects on cell differentiation, proliferation and adhesion in basal-like breast cancers.

Regional Centre of Applied and Molecular Oncology Masaryk Memorial Cancer Institute Zluty kopec 7 656 53 Brno Czech Republic

000      

00000naa a2200000 a 4500

001      

bmc17014131

003      

CZ-PrNML

005      

20191107095304.0

007      

ta

008      

170413s2016 xxu f 000 0|eng||

009      

AR

024    7_

$a 10.1007/s13277-016-4880-x $2 doi

035    __

$a (PubMed)26825981

040    __

$a ABA008 $b cze $d ABA008 $e AACR2

041    0_

$a eng

044    __

$a xxu

100    1_

$a Orzol, Paulina $u Regional Centre of Applied and Molecular Oncology, Masaryk Memorial Cancer Institute, Zluty kopec 7, 656 53, Brno, Czech Republic. $7 _AN073155

245    10

$a ΔNp63 regulates cell proliferation, differentiation, adhesion, and migration in the BL2 subtype of basal-like breast cancer / $c P. Orzol, M. Nekulova, J. Holcakova, P. Muller, B. Votesek, PJ. Coates,

520    9_

$a Triple-negative breast cancers (TNBC) comprise a heterogeneous subgroup of tumors with a generally poor prognosis. Subclassification of TNBC based on genomic analyses shows that basal-like TNBCs, specifically the basal A or BL2 subtype, are characterized by the expression of ΔNp63, a transcription factor that has been attributed a variety of roles in the regulation of proliferation, differentiation, and cell survival. To investigate the role(s) of p63 in basal-like breast cancers, we used HCC1806 cells that are classified as basal A/BL2. We show that these cells endogenously express p63, mainly as the ΔNp63α isoform. TP63 gene knockout by CRISPR resulted in viable cells that proliferate more slowly and adhere less tightly, with an increased rate of migration. Analysis of adhesion-related gene expression revealed a complex set of alterations in p63-depleted cells, with both increased and decreased adhesion molecules and adhesion substrates compared to parental cells expressing p63. Examination of the phenotype of these cells indicated that endogenous p63 is required to suppress the expression of luminal markers and maintain the basal epithelial phenotype, with increased levels of both CK8 and CK18 and a reduction in N-cadherin levels in cells lacking p63. On the other hand, the level of CK5 was not decreased and ER was not increased, indicating that p63 loss is insufficient to induce full luminal-type differentiation. Taken together, these data demonstrate that p63 exerts multiple pro-oncogenic effects on cell differentiation, proliferation and adhesion in basal-like breast cancers.

650    _2

$a CD antigeny $x biosyntéza $x genetika $7 D015703

650    _2

$a CRISPR-Cas systémy $7 D064113

650    _2

$a kadheriny $x biosyntéza $x genetika $7 D015820

650    _2

$a karcinom $x patologie $7 D002277

650    _2

$a buněčná adheze $7 D002448

650    _2

$a buněčná diferenciace $7 D002454

650    _2

$a nádorové buněčné linie $7 D045744

650    _2

$a proliferace buněk $7 D049109

650    _2

$a epitelové buňky $x metabolismus $x patologie $7 D004847

650    _2

$a ženské pohlaví $7 D005260

650    _2

$a regulace genové exprese u nádorů $7 D015972

650    _2

$a genový knockout $7 D055786

650    _2

$a lidé $7 D006801

650    _2

$a keratiny $x biosyntéza $x genetika $7 D007633

650    _2

$a nádorové proteiny $x fyziologie $7 D009363

650    _2

$a fenotyp $7 D010641

650    _2

$a protein - isoformy $x fyziologie $7 D020033

650    _2

$a transkripční faktory $x nedostatek $x fyziologie $7 D014157

650    _2

$a triple-negativní karcinom prsu $x patologie $7 D064726

650    _2

$a nádorové supresorové proteiny $x nedostatek $x fyziologie $7 D025521

655    _2

$a časopisecké články $7 D016428

700    1_

$a Nekulová, Marta $u Regional Centre of Applied and Molecular Oncology, Masaryk Memorial Cancer Institute, Zluty kopec 7, 656 53, Brno, Czech Republic. $7 xx0228718

700    1_

$a Holčáková, Jitka $u Regional Centre of Applied and Molecular Oncology, Masaryk Memorial Cancer Institute, Zluty kopec 7, 656 53, Brno, Czech Republic. $7 xx0125776

700    1_

$a Müller, Petr $u Regional Centre of Applied and Molecular Oncology, Masaryk Memorial Cancer Institute, Zluty kopec 7, 656 53, Brno, Czech Republic. $7 xx0036920

700    1_

$a Vojtěšek, Bořivoj, $u Regional Centre of Applied and Molecular Oncology, Masaryk Memorial Cancer Institute, Zluty kopec 7, 656 53, Brno, Czech Republic. vojtesek@mou.cz. $d 1960- $7 xx0001694

700    1_

$a Coates, Philip J. $u Regional Centre of Applied and Molecular Oncology, Masaryk Memorial Cancer Institute, Zluty kopec 7, 656 53, Brno, Czech Republic. philip.coates@mou.cz. $7 xx0228742

773    0_

$w MED00008757 $t Tumour biology the journal of the International Society for Oncodevelopmental Biology and Medicine $x 1423-0380 $g Roč. 37, č. 8 (2016), s. 10133-10140

856    41

$u https://pubmed.ncbi.nlm.nih.gov/26825981 $y Pubmed

910    __

$a ABA008 $b sig $c sign $y a $z 0

990    __

$a 20170413 $b ABA008

991    __

$a 20191107095535 $b ABA008

999    __

$a ok $b bmc $g 1200596 $s 974909

BAS    __

$a 3

BAS    __

$a PreBMC

BMC    __

$a 2016 $b 37 $c 8 $d 10133-10140 $e 20160129 $i 1423-0380 $m Tumor biology $n Tumor Biol $x MED00008757

GRA    __

$a NT14602 $p MZ0

LZP    __

$a Pubmed-20170413